Cell Source Inc Sustainability Reports
Cell Source, Inc. is a biotechnology company focused on developing cell therapy treatments based on immune tolerance management. Its proprietary Veto Cell technology is designed to safely facilitate mismatched donor stem cell and organ transplants while avoiding graft-versus-host disease.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG0046WCTP0
8 reports from 2015 to 2024
Company Profile
Cell Source, Inc. is a biotechnology company focused on developing cell therapy treatments based on immune tolerance management. Its proprietary Veto Cell technology is designed to safely facilitate mismatched donor stem cell and organ transplants while avoiding graft-versus-host disease.
Reports
8 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
